Samuel Beck, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Dermatology

PhD, Seoul National University
BS, Seoul National University



As the volume of cumulated biological data grows exponentially, its systematic analyses and interpretations become more and more critical. However, the synergy between computational and experimental biology can be challenging due to the difficulty of clear communication between these disciplines. As an interdisciplinary biologist, my overarching career goal is to study crucial biological questions through the combination of Big Data analytics and experimental validations. Specifically, throughout my postdoctoral training and independent career, I have studied mammalian gene regulatory mechanisms at the transcription level. Through integrative and comprehensive Big Data analysis, I discovered that CpG islands (CGIs) direct modes of gene regulation, including 3-D chromatin architectures and transcriptional/epigenetic regulations. This discovery has provided important clues to the mechanism by which changes in chromatin architecture contribute to age-associated physiological deterioration.

Diversity, Equity, Inclusion and Accessibility

2018-2021 Mentored multiple local and national undergraduate students (one underrepresented, two first-generation internationals, and two female students)


Loss of transcriptional homeostasis of genes lacking CpG islands during aging
06/01/2023 - 05/31/2026 (PI)
NIH/National Institute on Aging
5R01AG068179-05

DISARMing the immunological barriers to regeneration in mammals
02/01/2024 - 01/31/2026 (Subcontract PI)
Jackson Laboratory NIH NICHD
5R01HD110440-03

Hevolution/AFAR New Investigator Award in Biology and Geroscience Research
12/31/2022 - 12/31/2025 (Subcontract PI)
American Federation for Aging Research Hevolution Fdn


Chromatin architecture disruption and the vicious cycle of aging.
09/20/2023 - 08/31/2025 (PI)
NIH/National Institute on Aging
1R56AG082796-01



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Cha JH, Kim N, Ma J, Lee S, Koh G, Yang S, Beck S, Byeon I, Lee B, Lee I. A high-quality genomic catalog of the human oral microbiome broadens its phylogeny and clinical insights. Cell Host Microbe. 2025 Nov 12; 33(11):1977-1994.e8. PMID: 41167188; DOI: 10.1016/j.chom.2025.10.001;
     
  2. Kabir TD, Beck S, Stuart LM, Li J, Hou R, Liu P, Margolius S, Kim C, Choi YS, Bastow ER, Beveridge DJ, Spalding L, Li Z, Ginhoux F, Chow P, Phillips M, Redfern AD, Yeoh GC, Forrest A, Woo AJ, Sharma A, George J, McCaughan G, Leedman PJ. Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma. Cell Death Dis. 2025 Jul 25; 16(1):561. PMID: 40715090; PMCID: PMC12297225; DOI: 10.1038/s41419-025-07887-4;
     
  3. Geethadevi A, Vaidya N, Fisher RJ, Findlay T, Deng Y, Pham K, Kumar V, Beck S, Lucas CG, Eberhart CG, Xu J, Cole PA, Rubens J, Collard M, Raabe EH, Alani RM. The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models. bioRxiv. 2024 Dec 17. PMID: 39763800; PMCID: PMC11702534; DOI: 10.1101/2024.12.14.628381;
     
  4. Seo H, Kim S, Beck S, Song HY. Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology. Cells. 2024 Dec 04; 13(23). PMID: 39682751; PMCID: PMC11640688; DOI: 10.3390/cells13232003;
     
  5. Gladyshev VN, Anderson B, Barlit H, Barré B, Beck S, Behrouz B, Belsky DW, Chaix A, Chamoli M, Chen BH, Cheng K, Chuprin J, Churchill GA, Cipriano A, Colville A, Deelen J, Deigin Y, Edmonds KK, English BW, Fang R, Florea M, Gershteyn IM, Gill D, Goetz LH, Gorbunova V, Griffin PT, Horvath S, Borch Jensen M, Jin X, Jovanovska S, Kajderowicz KM, Kasahara T, Kerepesi C, Kulkarni S, Labunskyy VM, Levine ME, Libert S, Lu JY, Lu YR, Marioni RE, McCoy BM, Mitchell W, Moqri M, Nasirian F, Niimi P, Oh HS, Okundaye B, Parkhitko AA, Peshkin L, Petljak M, Poganik JR, Pridham G, Promislow DEL, Prusisz W, Quiniou M, Raj K, Richard D, Ricon JL, Rutledge J, Scheibye-Knudsen M, Schork NJ, Seluanov A, Shadpour M, Shindyapina AV, Shuken SR, Sivakumar S, Stoeger T, Sugiura A, Sutton NR, Suvorov A, Tarkhov AE, Teeling EC, Trapp A, Tyshkovskiy A, Unfried M, Ward-Caviness CK, Yim SH, Ying K, Yunes J, Zhang B, Zhavoronkov A. Disagreement on foundational principles of biological aging. PNAS Nexus. 2024 Dec; 3(12):pgae499.View Related Profiles. PMID: 39660064; PMCID: PMC11630784; DOI: 10.1093/pnasnexus/pgae499;
     
  6. Kumar V, Beck S. Single-cell multimodal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma. Clin Transl Discov. 2024 Oct; 4(5). PMID: 39444758; PMCID: PMC11495655; DOI: 10.1002/ctd2.70002;
     
  7. Batara DC, Kim HJ, Phan LT, Kim M, Son YO, Lee S, Park SI, Choi YS, Beck S, Kim SH. Elevated a-1,2-mannosidase MAN1C1 in glioma stem cells and its implications for immunological changes and prognosis in glioma patients. Sci Rep. 2024 Sep 27; 14(1):22159. PMID: 39333557; PMCID: PMC11436702; DOI: 10.1038/s41598-024-72901-2;
     
  8. Lee K, Barone M, Waterbury AL, Jiang H, Nam E, DuBois-Coyne SE, Whedon SD, Wang ZA, Caroli J, Neal K, Ibeabuchi B, Dhoondia Z, Kuroda MI, Liau BB, Beck S, Mattevi A, Cole PA. Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1. Nat Chem Biol. 2025 Feb; 21(2):227-237. PMID: 38965385; PMCID: PMC11699879; DOI: 10.1038/s41589-024-01671-9;
     
  9. Kim HJ, Batara DC, Jeon YJ, Lee S, Beck S, Kim SH. The impact of MEIS1 TALE homeodomain transcription factor knockdown on glioma stem cell growth. Anim Cells Syst (Seoul). 2024; 28(1):93-109. PMID: 38487309; PMCID: PMC10939110; DOI: 10.1080/19768354.2024.2327340;
     
  10. Wu M, Hanly A, Gibson F, Fisher R, Rogers S, Park K, Zuger A, Kuang K, Kalin JH, Nocco S, Cole M, Xiao A, Agus F, Labadorf A, Beck S, Collard M, Cole PA, Alani RM. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma. J Clin Invest. 2024 Feb 01; 134(6).View Related Profiles. PMID: 38300709; PMCID: PMC10940100; DOI: 10.1172/JCI171063;
     
Showing 10 of 39 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 39 publications over 17 distinct years, with a maximum of 8 publications in 2024

YearPublications
20071
20091
20102
20115
20121
20131
20143
20151
20162
20173
20182
20192
20213
20221
20231
20248
20252


2017 UT-Austin: Rom Rhome International Professional Development Award
2016 Department of Molecular Biosciences Retreat, UT-Austin: Best Poster Award
2015 KSEA West Gulf Coast Regional Conference / KoreanAmerican Biomedical Scientists Symposium: Best Talk/Poster Award
2015 Scientist and Engineers Early-career Development (SEED) Workshop: Travel Award for Outstanding Early Career Professionals
Contact for Mentoring:

609 Albany St
Boston MA 02118
Google Map


Beck's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department